Mary Zawadzki
Forum Topics Started
-
- Topic
- Voices
- Last Post
-
-
Braftovi/Mektovi (encorfenib/binimetinib)
Started by:
in: Targeted Therapy
- 1
- 4 months ago
-
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF
Started by:
in: Clinical Trials
- 1
- 4 months, 2 weeks ago
-
Adjuvant Immunotherapy With Relatlimab and Nivolumab Versus Nivolumab alone
Started by:
in: Clinical Trials
- 1
- 4 months, 2 weeks ago
-
Libtayo® (cemiplimab) provincial funding
Started by:
in: Cutaneous Squamous Cell Carcinoma (CSCC)
- 1
- 5 months, 3 weeks ago
-
Health Canada approve KIMMTRAK® (tebentafusp)
Started by:
in: Uveal Melanoma Patients
- 1
- 5 months, 3 weeks ago
-
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation
Started by:
in: Clinical Trials
- 1
- 5 months, 4 weeks ago
-
New Basal-Cell-Carcinoma-BCC-Patient-Guide
Started by:
in: Basal Cell Carcinoma (BCC)
- 1
- 5 months, 4 weeks ago
-
Opdualag Becomes First FDA-Approved Immunotherapy to Target LAG-3
Started by:
in: Clinical Trials
- 1
- 5 months, 4 weeks ago
-
eye patch day
Started by:
in: Uveal Melanoma Patients
- 1
- 6 months, 1 week ago
-
FDA Grants Orphan Drug Designation to Darovasertib for Uveal Melanoma Treatment
Started by:
in: Uveal Melanoma Patients
- 1
- 6 months, 2 weeks ago
-
Landmarks across Canada will be illuminated to recognize Melanoma Month
Started by:
in: Upcoming Events & Meetings
- 1
- 6 months, 4 weeks ago
-
Adjuvant Pembrolizumab (Keytruda) for Stage IIb or IIc Melanoma Patients
Started by:
in: Adjuvant Therapy
- 1
- 7 months, 1 week ago
-
Adjuvant Pembrolizumab (Keytruda) for Stage IIb or IIc Melanoma Patients
Started by:
in: Immunotherapy
- 1
- 7 months, 1 week ago
-
Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II
Started by:
in: Acral Lentiginous Melanoma
- 1
- 7 months, 1 week ago
-
SORTT
Started by:
in: Uveal Melanoma Patients
- 1
- 7 months, 1 week ago
-
Braftovi/Mektovi (encorfenib/binimetinib)
